79227419 - SPLEEN TO SCREEN

Information

• Trademark
• 79227419

• Source

• Serial Number

  79227419

• Registration Number

  5830546

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services
  • 45 - Legal services

• Filing Date

  July 21, 2017
  6 years ago

• Registration Date

  August 13, 2019
  4 years ago

• Transaction Date

  January 25, 2024
  5 months ago

• Status Date

  August 13, 2019
  4 years ago

• Published for Opposition Date

  May 28, 2019
  5 years ago

• Location Date

  August 13, 2019
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  NELMAN, JESSE M

• Attorney Docket Number

  11137T00040U

  Attorney Name

  Peter Silverman

  Law Office Assigned Location Code

  M40

• Owners

  • Merus B.V.

Case File Statements

• GS0051: Pharmaceutical and veterinary preparations prepared with antibodies in the nature of protein mixtures used in the medical and pharmaceutical industry and in science for the treatment of cancer and other therapeutic indications, namely, for the generation of mono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases
• GS0011: Biochemical products used in the medical and pharmaceutical industry and in science, in particular antibodies in the nature of protein mixtures for rapidly screening panels of target-specific antibodies for the downstream production of, and for the manufacture of, mono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases
• GS0451: Legal services; legal services relating to exploitation of intellectual property rights; licensing of intellectual property rights; legal advisory services in the aforementioned fields, namely, exploitation of intellection property rights and licensing of intellectual property rights, concerning rapid screening of panels of target-specific antibodies for the downstream production of, and for the manufacture of, mono and multispecific biologics in the fields of immuno-oncology and auto-immune diseases
• GS0441: Medical services; veterinary services; genetic testing of research animals, in particular of transgenic mice for research purposes
• GS0421: Services of biochemists, namely, scientific and medical laboratory services in the nature of efficient screening of antibodies in the nature of protein mixtures for the generation of mono and multispecific biologics; services of bacteriologic and biochemical laboratories, namely, research in the field of biochemistry; professional advice relating to biochemistry; conducting scientific and industrial research using laboratory techniques, namely, the extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and preparing related professional reports; professional advice relating to scientific and industrial research using laboratory techniques, namely, the extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; reviewing and analyzing anti-bodies in the nature of protein mixtures used in the medical and pharmaceutical industry and in science and the preparation of related professional reports for scientists, engineers, analysts and laboratory assistants and technicians for industry and government services; scientific and industrial research, in particular in the field of the aforementioned anti-bodies, namely, anti-bodies in the nature of protein mixtures; research and development of new products for others, in particular anti-bodies in the nature of protein mixtures; chemical and laboratory research services, namely, performing extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; consultancy relating to chemical and laboratory research services, namely, the performance of extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports

Case File Event Statements

• 7/30/2023 - 11 months ago

  45 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 7/30/2023 - 11 months ago

  44 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/30/2023 - 11 months ago

  43 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 7/30/2023 - 11 months ago

  42 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/30/2023 - 11 months ago

  41 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 7/30/2023 - 11 months ago

  40 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 7/30/2023 - 11 months ago

  39 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 12/13/2019 - 4 years ago

  38 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 11/26/2019 - 4 years ago

  37 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 11/26/2019 - 4 years ago

  36 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/13/2019 - 4 years ago

  35 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 8/13/2019 - 4 years ago

  34 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/9/2019 - 4 years ago

  33 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 7/24/2019 - 4 years ago

  32 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 7/24/2019 - 4 years ago

  31 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 5/28/2019 - 5 years ago

  30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/28/2019 - 5 years ago

  29 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/24/2019 - 5 years ago

  28 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 5/8/2019 - 5 years ago

  27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 5/8/2019 - 5 years ago

  26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/8/2019 - 5 years ago

  25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 4/19/2019 - 5 years ago

  24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/19/2019 - 5 years ago

  23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/19/2019 - 5 years ago

  22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 4/19/2019 - 5 years ago

  21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/19/2019 - 5 years ago

  20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/3/2019 - 5 years ago

  19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/3/2019 - 5 years ago

  18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/3/2019 - 5 years ago

  17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/9/2018 - 5 years ago

  16 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/9/2018 - 5 years ago

  15 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/9/2018 - 5 years ago

  14 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/14/2018 - 5 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/14/2018 - 5 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/14/2018 - 5 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 9/5/2018 - 5 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/24/2018 - 6 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 3/8/2018 - 6 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 3/8/2018 - 6 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/6/2018 - 6 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/2/2018 - 6 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/1/2018 - 6 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/28/2018 - 6 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/28/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/22/2018 - 6 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR